Gp Act Iii Acquisition Stock Performance

GPATW Stock   0.27  0.0004  0.15%   
On a scale of 0 to 100, GP Act holds a performance score of 4. The company owns a Beta (Systematic Risk) of 0.54, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, GP Act's returns are expected to increase less than the market. However, during the bear market, the loss of holding GP Act is expected to be smaller as well. Please check GP Act's standard deviation and the relationship between the value at risk and market facilitation index , to make a quick decision on whether GP Act's current price history will revert.

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in GP Act III Acquisition are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, GP Act showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1
Real time breakdown of GP Act III Acquisition Corp. Debt Equity Composite Units stock performance - Market Sentiment Report Weekly Momentum Picks - newser.com
09/30/2025
2
What risks investors should watch in GP Act III Acquisition Corp. stock - 2025 Price Targets Entry Point Confirmation Alerts - Newser
12/04/2025
3
Quarterly Risk Is GP Act III Acquisition Corp. stock overvalued by current metrics - Quarterly Trade Review Consistent Return Investment Signals - DonanmHaber
12/19/2025
4
GPATU Stock Institutional Owners - Quiver Quantitative
12/23/2025
Begin Period Cash Flow1208.00
Total Cashflows From Investing Activities-287.5 M
Free Cash Flow-584.7 K

GP Act Relative Risk vs. Return Landscape

If you would invest  25.00  in GP Act III Acquisition on October 2, 2025 and sell it today you would earn a total of  1.96  from holding GP Act III Acquisition or generate 7.84% return on investment over 90 days. GP Act III Acquisition is currently producing 0.6346% returns and takes up 10.3047% volatility of returns over 90 trading days. Put another way, 92% of traded stocks are less volatile than GPATW, and 88% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon GP Act is expected to generate 14.27 times more return on investment than the market. However, the company is 14.27 times more volatile than its market benchmark. It trades about 0.06 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.

GP Act Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for GP Act's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as GP Act III Acquisition, and traders can use it to determine the average amount a GP Act's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0616

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsGPATW
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns
Based on monthly moving average GP Act is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GP Act by adding it to a well-diversified portfolio.

GP Act Fundamentals Growth

GPATW Stock prices reflect investors' perceptions of the future prospects and financial health of GP Act, and GP Act fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GPATW Stock performance.

About GP Act Performance

Evaluating GP Act's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if GP Act has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if GP Act has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.03  0.03 
Return On Assets 0.03  0.03 
Return On Equity 0.03  0.03 

Things to note about GP Act III performance evaluation

Checking the ongoing alerts about GP Act for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for GP Act III help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
GP Act III is way too risky over 90 days horizon
GP Act III has some characteristics of a very speculative penny stock
GP Act III appears to be risky and price may revert if volatility continues
GP Act III has high likelihood to experience some financial distress in the next 2 years
GP Act generates negative cash flow from operations
GP Act III has a poor financial position based on the latest SEC disclosures
Latest headline from news.google.com: GPATU Stock Institutional Owners - Quiver Quantitative
Evaluating GP Act's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate GP Act's stock performance include:
  • Analyzing GP Act's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GP Act's stock is overvalued or undervalued compared to its peers.
  • Examining GP Act's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating GP Act's management team can have a significant impact on its success or failure. Reviewing the track record and experience of GP Act's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of GP Act's stock. These opinions can provide insight into GP Act's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating GP Act's stock performance is not an exact science, and many factors can impact GP Act's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for GPATW Stock Analysis

When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.